ALLISON CLAY: Open Payments
NPI 1689230237 · TAYLORSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 11 payments from 8 companies in 2025. Trend: 2023 $57 · 2024 $363 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Novo Nordisk Inc | 2 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Organon LLC | 1 | $10 |
| Phathom Pharmaceuticals, Inc. | 1 | $9 |
Products named: AIRSUPRA, ZENPEP, VRAYLAR, Ozempic, MOUNJARO, BREZTRI, Rybelsus, PROQUAD.
Industry payments across NC — which companies pay providers there.
